Affiliation:
1. Department of Rheumatology and Immunology Third Affiliated Hospital of Sun Yat‐Sen University Guangzhou Guangdong China
Abstract
AbstractObjectivesTo determine the alteration of peripheral T and B cell subsets in patients with systemic sclerosis (SSc) and to evaluate their correlation with the progression of SSc.MethodsWe recruited 47 SSc patients and 45 healthy controls (HCs) in this study. Demographic and clinical data were then collected. Flow cytometry was used to detect the proportions of 44 different T and B cell subsets in circulating blood.ResultsThe proportion of total B cells (p = .043) decreased in SSc patients, together with similar frequencies of total T cells, CD4+ T cells, and CD8+ T cells in both groups. Several subsets of T and B cells differed significantly between these two groups. Follicular helper T cells‐1 (Tfh1) (p < .001), helper T cells‐1 (Th1) (p = .001), regulatory T cells (Treg) (p = .004), effector memory CD8+ T cells (p = .041), and cytotoxic T cells‐17 (Tc17) (p = .01) were decreased in SSc patients. Follicular helper T cells‐2 (Tfh2) (p = .001) and, helper T cells‐2 (Th2) (p = .001) levels increased in the SSc group. Regulatory B cells (Breg) (p = .015) were lower in the SSc group, together with marginal zone (MZ) B cells (p < .001), memory B cells (p = .001), and non‐switched B cells (p = .005). The modified Rodnan skin score (mRSS) correlated with helper T cells‐17 (Th17) (r = −.410, p = .004), Tfh1 (r = −.321, p = .028), peripheral helper T cells (Tph) (r = −.364, p = .012) and plasma cells (r = −.312, p = .033).ConclusionsThe alterations in T and B cells implied immune dysfunction, which may play an essential role in systemic sclerosis.
Reference47 articles.
1. Systemic sclerosis
2. Systemic sclerosis: Current concepts of skin and systemic manifestations
3. Scleroderma
4. The fibroblast in systemic sclerosis
5. The aetiopathogenesis of systemic sclerosis: thick skin—thin hypotheses. The Parkes weber lecture 1994;Black CM;J R Coll Physicians Lond,1995